Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank86
3Y CAGR+80.3%
5Y CAGR+121.3%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+80.3%/yr
Annual compound
5Y CAGR
+121.3%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
53.1x
Strong expansion
| Period | Value | YoY Change |
|---|---|---|
| TTM | $37.78M | 0.0% |
| 2024 | $37.78M | +103.5% |
| 2023 | $18.57M | +188.0% |
| 2022 | $6.45M | +1960.1% |
| 2021 | $313000.00 | -56.0% |
| 2020 | $711000.00 | -25.9% |
| 2019 | $959000.00 | +6093.8% |
| 2018 | $-16000.00 | - |